Vulnerability in Baxter Prismaflex
CVE-2020-12037
Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS (Patient Data Management System) or an EMR (Electronic Medical Record) system. An attacker could observe sensitive data sent from the device.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.
EPSS exploit prediction
EPSS: 0.005 (39.2th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 39th percentile — 39.2% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.005 · newest: 0.005 · change: 0.000
Affected products
- Baxter Prismaflex
- Baxter Prismaflex Firmware
- Baxter Prismax
- Baxter Prismax Firmware
- Baxter Prismaflex And Prismax — versions PrismaFlex all versions, PrisMax all versions prior to 3.x
Weakness classification (CWE)
References
- www.us-cert.gov/ics/advisories/icsma-20-170-01 (Not Applicable)
- us-cert.cisa.gov/ics/advisories/icsma-20-170-02 (Third Party Advisory)
Frequently asked questions
- What is CVE-2020-12037?
- CVE-2020-12037 is a high-severity vulnerability in Baxter Prismaflex, classified under Use of Hard-coded Password. CVSS score: 7.5/10. Published 2020-06-29.
- How severe is CVE-2020-12037?
- High severity. CVSS v3 base score is 7.5 out of 10.